CLINICOM, founded in 2004 and headquartered in the United States, is reshaping the landscape of mental health care with its groundbreaking platform. Described as the "World’s First Comprehensive DSM based Clinical Decision support platform and Augmented Intelligence for mental health," CLINICOM offers an advanced solution that addresses over 80 DSM conditions using augmented intelligence and machine learning.
Operating in the intersections of Health Care, Health and Wellness, and Information Technology, CLINICOM aims to streamline clinical operations and improve care delivery. Its platform not only supports diagnostic and treatment insights but also integrates into care models as a reimbursable solution, enhancing both clinical efficiency and patient access to care.
CLINICOM secured a Seed Round investment of $800.00K on 14 December 2022. This financial step bolsters its mission to revolutionize mental health services, potentially lowering healthcare costs while setting a new benchmark for patient outcomes in the field.